4-butyrolactone has been researched along with Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kliner, M; Tomkins, A; Vivancos, R; Ward, C | 1 |
| Chen, L; Chung, CY; Jassey, A; Li, CL; Lin, CC; Lin, LT; Liu, CH; Wang, GH; Yen, MH | 1 |
2 other study(ies) available for 4-butyrolactone and Hepatitis C
| Article | Year |
|---|---|
How can those engaging in chemsex best be supported? An online survey to gain intelligence in Greater Manchester.
Topics: 4-Butyrolactone; Adult; Coinfection; Harm Reduction; Hepatitis C; HIV Infections; Homosexuality, Male; Humans; Internet; London; Male; Methamphetamine; Middle Aged; Risk-Taking; Sexual Behavior; Sexual Partners; Sodium Oxybate; Substance-Related Disorders; Surveys and Questionnaires; Unsafe Sex; Young Adult | 2018 |
(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry.
Topics: 4-Butyrolactone; Adsorption; Antiviral Agents; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Hepacivirus; Hepatitis C; Humans; Immunity; Microscopy, Confocal; Phyllanthus; Reproducibility of Results; Virion; Virus Activation; Virus Internalization | 2016 |